Partial heart transplant grafts remain viable during prolonged cold preservation, far exceeding traditional heart transplant ischemia limits. This breakthrough could revolutionize transplant logistics, enabling wider donor access and reducing wait times for life-saving, growth-capable heart valve implants.
Hyperkalemia and hyponatremia in HSCT and solid organ transplant recipients should alert the clinician for CNI-related side effects; renin and aldosterone should be measured. Hyporeninemic hypoaldosteronism is the suggested underlying mechanism.
Please check your email for instructions on resetting your password.
If you do not receive an email within 10 minutes, your email address may not be registered,
and you may need to create a new Wiley Online Library account.
Request Username
Can't sign in? Forgot your username?
Enter your email address below and we will send you your username
If the address matches an existing account you will receive an email with instructions to retrieve your username